TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07005050: Renal Pelvic Denervation Pilot Trial

Sponsor: Verve Medical, Inc · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 60 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT07005050 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07005050 Rescue Dossier →